MacroGenics PE Ratio 2012-2025 | MGNX

Current and historical p/e ratio for MacroGenics (MGNX) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MacroGenics PE ratio as of May 22, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

MacroGenics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-22 1.58 0.00
2025-03-31 1.27 $-0.24 0.00
2024-12-31 3.25 $-1.08 0.00
2024-09-30 3.29 $-1.58 0.00
2024-06-30 4.25 $-2.20 0.00
2024-03-31 14.72 $-0.39 0.00
2023-12-31 9.62 $-0.16 0.00
2023-09-30 4.66 $0.80 5.83
2023-06-30 5.35 $0.12 44.58
2023-03-31 7.17 $-1.47 0.00
2022-12-31 6.71 $-1.94 0.00
2022-09-30 3.46 $-3.10 0.00
2022-06-30 2.95 $-3.56 0.00
2022-03-31 8.81 $-3.55 0.00
2021-12-31 16.05 $-3.37 0.00
2021-09-30 20.94 $-2.40 0.00
2021-06-30 26.86 $-2.20 0.00
2021-03-31 31.85 $-2.48 0.00
2020-12-31 22.86 $-2.49 0.00
2020-09-30 25.19 $-3.13 0.00
2020-06-30 27.92 $-3.38 0.00
2020-03-31 5.82 $-3.09 0.00
2019-12-31 10.88 $-3.17 0.00
2019-09-30 12.76 $-3.61 0.00
2019-06-30 16.97 $-3.51 0.00
2019-03-31 17.98 $-3.89 0.00
2018-12-31 12.70 $-4.24 0.00
2018-09-30 21.44 $-0.38 0.00
2018-06-30 20.65 $-0.85 0.00
2018-03-31 25.16 $-0.96 0.00
2017-12-31 19.00 $-0.70 0.00
2017-09-30 18.48 $-4.50 0.00
2017-06-30 17.51 $-4.19 0.00
2017-03-31 18.60 $-1.93 0.00
2016-12-31 20.44 $-1.73 0.00
2016-09-30 29.91 $-1.62 0.00
2016-06-30 26.99 $-1.11 0.00
2016-03-31 18.75 $-2.94 0.00
2015-12-31 30.97 $-0.64 0.00
2015-09-30 21.42 $-0.44 0.00
2015-06-30 37.97 $-0.12 0.00
2015-03-31 31.37 $0.15 209.13
2014-12-31 35.07 $-1.39 0.00
2014-09-30 20.90 $-0.84 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.094B $0.150B
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.485B 27.83
Boston Scientific (BSX) United States $154.809B 38.76
Stryker (SYK) United States $144.946B 30.31
EssilorLuxottica (ESLOY) France $134.105B 0.00
Medtronic (MDT) Ireland $108.260B 15.35
Haleon (HLN) United Kingdom $50.025B 28.46
Lonza Group Ag (LZAGY) Switzerland $49.059B 0.00
ResMed (RMD) United States $36.038B 27.07
GE HealthCare Technologies (GEHC) United States $31.860B 15.13
Agilent Technologies (A) United States $31.051B 20.51
Terumo (TRUMY) Japan $27.450B 35.65
Insulet (PODD) United States $22.837B 89.64
Koninklijke Philips (PHG) Netherlands $22.023B 15.83
Zimmer Biomet Holdings (ZBH) United States $18.348B 11.78
Baxter (BAX) United States $15.616B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $12.578B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.204B 21.59
Lantheus Holdings (LNTH) United States $5.198B 13.11
Prestige Consumer Healthcare (PBH) United States $4.172B 18.64
Perrigo (PRGO) Ireland $3.700B 9.38
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.362B 14.64
ICU Medical (ICUI) United States $3.218B 23.73
Envista Holdings (NVST) United States $2.820B 23.44
GN Store Nord (GNNDY) Denmark $2.097B 17.37
QuidelOrtho (QDEL) United States $2.000B 13.76
LeMaitre Vascular (LMAT) United States $1.841B 41.16
AtriCure (ATRC) United States $1.647B 0.00
Neogen (NEOG) United States $1.350B 17.28
Acuren (TIC) United States $1.305B 0.00
AdaptHealth (AHCO) United States $1.223B 12.41
Kestra Medical Technologies (KMTS) United States $1.186B 0.00
Green Thumb Industries (GTBIF) United States $1.169B 26.29
BioLife Solutions (BLFS) United States $1.049B 0.00
Phibro Animal Health (PAHC) United States $0.942B 12.05
InMode (INMD) Israel $0.898B 9.05
CeriBell (CBLL) United States $0.634B 0.00
Evolus (EOLS) United States $0.618B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.573B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Owens & Minor (OMI) United States $0.531B 4.40
Valneva SE (VALN) France $0.527B 0.00
Capricor Therapeutics (CAPR) United States $0.508B 0.00
Tilray Brands (TLRY) Canada $0.436B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.344B 0.00
Cresco Labs (CRLBF) United States $0.338B 0.00
Canopy Growth (CGC) Canada $0.331B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
VAREX IMAGING (VREX) United States $0.315B 11.58
Aurora Cannabis (ACB) Canada $0.293B 52.20
Sanara MedTech (SMTI) United States $0.276B 0.00
Sanuwave Health (SNWV) United States $0.267B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Verano Holdings (VRNOF) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.237B 10.78
Biote (BTMD) United States $0.212B 5.95
Brainsway (BWAY) Israel $0.196B 52.00
OraSure Technologies (OSUR) United States $0.190B 0.00
Quanterix (QTRX) United States $0.187B 0.00
High Tide (HITI) Canada $0.186B 0.00
Omeros (OMER) United States $0.182B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
TriSalus Life Sciences (TLSI) United States $0.176B 0.00
Utah Medical Products (UTMD) United States $0.173B 14.11
FitLife Brands (FTLF) United States $0.131B 16.07
Jin Medical (ZJYL) China $0.125B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.113B 0.00
Agape ATP (ATPC) $0.105B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Fonar (FONR) United States $0.085B 10.96
Quipt Home Medical (QIPT) United States $0.084B 0.00
InterCure (INCR) Israel $0.072B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
United Health Products (UEEC) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
United-Guardian (UG) United States $0.039B 13.44
Modular Medical (MODD) United States $0.035B 0.00
Rockwell Medical (RMTI) United States $0.034B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.024B 32.29
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00